Dr. Paul Emery, a renowned expert in rheumatology and early intervention for rheumatoid arthritis, discusses the complex process of tapering biologic therapies. He shares insights from his latest study on predicting flares, emphasizing the importance of individualizing treatment based on patient characteristics. The conversation highlights the evolution of remission strategies, patient-centric approaches, and the necessity of biomarker testing. Emery also touches on the role of mentorship in advancing rheumatology practices, showcasing the human side of patient care.